Get started
Work

Phase I Trial of Humanized CD19 CART-Cell Therapy Developed in India: Safe, Active and Feasible for Outpatient Therapy

Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2022-166082
Authors: Hasmukh Jain, Atharva Karulkar, Neha Sharma, Manju Sengar, Ankesh Jaiswal, Shreshtha Shah, Aalia Khan, Afrin Firfiray, Sweety Asija, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Devanshi Kalra, Smrithi Ravikumar, Gaurav Narula, Shripad Banavali, Minal Poojary, Sumathi Hiregoudar, Lingaraj Nayak, Bhausaheb Bagal, Prashant R. Tembhare, Sridhar Epari, Navin Khattry, Nikhil Patkar, Sumeet Gujral, Tanuja Shet, Papagudi Ganesan Subramanian, Jayashree Thorat, Sachin Punatar, Anant Gokarn, Kinjalka Ghosh, Archi Agarwal, Preeti Desai, Shashank Ojha, Subhash Yadav, Shil Pushp Bhosale, Sunil Rajadhyaksha, Anisha Navkudkar, Siddharth Laskar, Sumeet Prakash Mirgh, Albeena Nisar, Deepali Pandit, Ruchira Patil, Rahul Purwar, Sattva S. Neelapu, Nirali N. Shah
Institutions: Homi Bhabha National Institute, Tata Memorial Hospital, Indian Institute of Technology Bombay, Advanced Centre for Treatment, Research and Education in Cancer, The University of Texas MD Anderson Cancer Center, National Institutes of Health, National Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4310163226
FWCI: 0.456
Cites:
Cited by: 5
Related to: 10